检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:范月梅 周彩莲 周纯 FAN Yuemei;ZHOU Cailian;ZHOU Chun(The Maternal and Child Health and Family Planning Service Center of Fogang County/The Women and Children's Hospital of Fogang County,Qingyuan 511600,China)
机构地区:[1]广东省佛冈县妇幼保健计划生育服务中心/广东省佛冈县妇女儿童医院,广东清远511600
出 处:《临床医学工程》2021年第6期809-810,共2页Clinical Medicine & Engineering
摘 要:目的探讨温经暖宫汤联合米非司酮片治疗子宫内膜异位症痛经的临床疗效。方法70例子宫内膜异位症痛经患者随机分为两组各35例,对照组给予米非司酮片治疗,治疗组给予温经暖宫汤联合米非司酮片治疗,比较两组的疗效及VAS评分。结果治疗3个月后,治疗组的总有效率为88.6%,显著高于对照组的65.7%(P<0.05)。治疗3个月后,两组的VAS评分均较治疗前显著下降,且治疗组的VAS评分显著低于对照组(P<0.05)。治疗期间两组均未出现肝肾功能异常、阴道出血等不良反应。结论温经暖宫汤联合米非司酮片能有效缓解子宫内膜异位症痛经患者的痛经症状,且安全性较高。Objective To explore the clinical efficacy of Wenjing Nuangong decoction combined with mifepristone tablets in the treatment of endometriosis dysmenorrhea.Methods 70 patients with endometriosis dysmenorrhea were randomly divided into two groups,with 35 cases in each group.The control group was treated with mifepristone tablets,and the treatment group was treated with Wenjing Nuangong decoction combined with mifepristone tablets.The efficacy and VAS score were compared between two groups.Results After 3 months of treatment,the total effective rate of the treatment group was 88.6%,significantly higher than 65.7%of the control group(P<0.05).After 3 months of treatment,the VAS scores in both groups were significantly lower than those before treatment,and the VAS score of treatment group was significantly lower than that of control group(P<0.05).During the treatment,no adverse reaction such as abnormal liver and kidney function,or vagina hemorrhage occurred in both groups.Conclusions Wenjing Nuangong decoction combined with mifepristone tablets can effectively relieve the dysmenorrhea symptom of patients with endometriosis dysmenorrhea,and has high safety.
分 类 号:R271.113[医药卫生—中医妇科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7